Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Chlordinium, Librax
Synonyms :
chlordiazepoxide/clidinium
Class :
Gastrointestinal Agents and Anticholinergics / antispasmodics
Dosage Forms & Strengths
Capsule
5mg/2.5mg- chlordiazepoxide/clidinium
Safety and efficacy not established
It may enhance the serum concentration when combined with CYP3A4 Substrates
Adverse drug reactions
Frequency Not Defined
Agranulocytosis
Skin eruptions
Drowsiness
Ataxia
Menstrual irregularities
Confusion
Jaundice
Hepatic dysfunction
Edema
Extrapyramidal symptoms
Nausea
Constipation
Xerostomia
Pregnancy warnings:
AU TGA pregnancy category: N/A
US FDA pregnancy category: N/A
Lactation:
Excreted into human milk is known (chlordiazepoxide); Unknown (chlordiazepoxide-clidinium)
Pregnancy Categories:
Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.
Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient Information Leaflet
Generic Name: chlordiazepoxide/clidinium
Why do we use chlordiazepoxide/clidinium?
chlordiazepoxide/clidinium is a gastrointestinal agent used to treat peptic ulcers.